Latest Earnings Results: Q3 '26
Estimated EPS
$0.56
Reported EPS
$0.59
Surprise
+5.85%
Estimated Rev
$413.16M
Reported Rev
$411.18M
Surprise
-0.48%
• Reported GAAP EPS of $0.59 up 9.26% YoY • Reported revenue of $411.18M up 2.27% YoY • Integra LifeSciences expects Q4 2026 revenue of $413M to $433M and adjusted diluted EPS of $0.61 to $0.71; FY2026 revenue of $1.63B to $1.65B and adjusted EPS of $2.30 to $2.40.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.64 | -- | -- | N/A |
Q3 '26 | $0.56 | $0.59 | 5.85% | BEAT |
Q2 '26 | $0.48 | $0.56 | 16.55% | BEAT |
Q1 '26 | $0.40 | $0.54 | 33.35% | BEAT |
Q4 '25 | $0.80 | $0.83 | 3.73% | BEAT |